{"Title": "Oligonucleotide Drugs for Transthyretin Amyloidosis", "Year": 2018, "Source": "N. Engl. J. Med.", "Volume": "379", "Issue": 21, "Art.No": null, "PageStart": 2086, "PageEnd": null, "CitedBy": 5, "DOI": "10.1056/NEJMc1810994", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85057523088&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Amyloid Neuropathies, Familial", "Amyloidosis", "Humans", "Oligonucleotides", "Prealbumin"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-85057523088", "SubjectAreas": [["Medicine (all)", "MEDI", "2700"]], "AuthorData": {"57209645416": {"Name": "Adams D.", "AuthorID": "57209645416", "AffiliationID": "60013430", "AffiliationName": "Assistance Publique\u2013H\u00f4pitaux de Paris"}, "35464959200": {"Name": "Hawkins P.", "AuthorID": "35464959200", "AffiliationID": "60022148", "AffiliationName": "University College London"}, "6603076622": {"Name": "Polydefkis M.", "AuthorID": "6603076622", "AffiliationID": "60006433", "AffiliationName": "Johns Hopkins Medicine"}}}